These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15866697)

  • 21. Plasmapheresis as rescue therapy in accelerated acute humoral rejection.
    Abraham KA; Brown C; Conlon PJ; Donohoe J; Hickey DP; O'Neill D; Keogan MT; Dorman AM; Walshe J
    J Clin Apher; 2003; 18(3):103-10. PubMed ID: 14569599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X; Ishida H; Yamaguchi Y; Tanabe K
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of donor age and acute rejection episodes on long-term graft survival in cadaveric kidney transplantations.
    Emiroğlu R; Yagmurdur MC; Karakayali F; Haberal C; Ozcelik U; Colak T; Haberal M
    Transplant Proc; 2005 Sep; 37(7):2954-6. PubMed ID: 16213272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Multimodal treatment for acute antibody-mediated renal transplant rejection: successful rescue therapy with combined plasmapheresis, photopheresis and intravenous immunoglobulin].
    Lai Q; Pretagostini R; Gozzer M; Cinti P; Meo D; Vita F; Bafti MS; Poli L; Novelli G; Rossi M; Girelli G; Berloco PB
    G Ital Nefrol; 2012; 29 Suppl 54():S31-5. PubMed ID: 22388827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clearance of C4d deposition after successful treatment of acute humoral rejection in follow-up biopsies: a report of three cases.
    Koller H; Steurer W; Mark W; Margreiter R; Lhotta K; Mayer G; Rosenkranz AR
    Transpl Int; 2004 May; 17(4):177-81. PubMed ID: 15114439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of plasmapheresis for acute humoral rejection after heart transplantation.
    Wang SS; Chou NK; Ko WJ; Chi NH; Hung SC; Hsu RB; Yu HY; Chen YS; Chu SH; Tsao CI; Shun CT
    Transplant Proc; 2006 Dec; 38(10):3692-4. PubMed ID: 17175369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: Analysis of UNOS Database.
    Simpson N; Cho YW; Cicciarelli JC; Selby RR; Fong TL
    Transplantation; 2006 Nov; 82(10):1298-303. PubMed ID: 17130778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.
    Montgomery RA; Zachary AA; Racusen LC; Leffell MS; King KE; Burdick J; Maley WR; Ratner LE
    Transplantation; 2000 Sep; 70(6):887-95. PubMed ID: 11014642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bortezomib is effective to treat acute humoral rejection after liver transplantation.
    Lee CF; Eldeen FZ; Chan KM; Wu TH; Soong RS; Wu TJ; Chou HS; Lee WC
    Transplant Proc; 2012 Mar; 44(2):529-31. PubMed ID: 22410063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of two different preconditioning regimens for ABO-incompatible living kidney donor transplantation. A comparison of splenectomy vs. rituximab-treated non-splenectomy preconditioning regimens.
    Tanabe K; Ishida H; Shimizu T; Omoto K; Shirakawa H; Tokumoto T
    Contrib Nephrol; 2009; 162():61-74. PubMed ID: 19001814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C, acute humoral rejection, and renal allograft survival.
    Forman JP; Tolkoff-Rubin N; Pascual M; Lin J
    J Am Soc Nephrol; 2004 Dec; 15(12):3249-55. PubMed ID: 15579529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin.
    Leech SH; Lopez-Cepero M; LeFor WM; DiChiara L; Weston M; Furukawa S; Macha M; Singhal A; Wald JW; Nikolaidis LA; McClurken JB; Bove AA
    Clin Transplant; 2006; 20(4):476-84. PubMed ID: 16842525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.
    Fehr T; Rüsi B; Fischer A; Hopfer H; Wüthrich RP; Gaspert A
    Transplantation; 2009 Jun; 87(12):1837-41. PubMed ID: 19543061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of simultaneous acute antibody-mediated rejection and acute cellular rejection with alemtuzumab in kidney transplantation: a case report.
    Jirasiritham S; Khunprakant R; Techawathanawanna N; Jirasiritham S; Mavichak V
    Transplant Proc; 2010 Apr; 42(3):987-9. PubMed ID: 20430222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peritubular capillary C4d staining in late acute renal allograft rejection--is it relevant?
    Satoskar AA; Lehman AM; Nadasdy GM; Sedmak DD; Pesavento TE; Henry ML; Pelletier RP; Ferguson RM; Nadasdy T
    Clin Transplant; 2008; 22(1):61-7. PubMed ID: 18217907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
    Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute humoral rejection after kidney transplantation: a report of two cases.
    Haberal M; Sevmis S; Karakayali H; Ozdemir N; Demirhan B; Moray G; Turan M; Arslan H
    Clin Transpl; 2006; ():513-7. PubMed ID: 18365415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.
    Waiser J; Budde K; Schütz M; Liefeldt L; Rudolph B; Schönemann C; Neumayer HH; Lachmann N
    Nephrol Dial Transplant; 2012 Mar; 27(3):1246-51. PubMed ID: 21852274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome after kidney transplantation in children with thrombotic risk factors.
    Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antibody-mediated acute rejection].
    Lefaucheur C; Nochy D; Glotz D
    Nephrol Ther; 2008 Oct; 4 Suppl 3():S188-91. PubMed ID: 19000885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.